ArticleResearch and practice in thrombosis and haemostasis2026
Maternal and neonatal outcomes in pregnant women with severe thrombocytopenia: insights from a retrospective 8-year cohort study in China.
Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Severe thrombocytopenia during pregnancy is uncommon but poses substantial challenges for obstetric management because of potential maternal bleeding and adverse neonatal outcomes. However, the relationship between the severity of maternal thrombocytopenia and maternal-neonatal outcomes remains unclear. Objectives: To characterize clinical features and maternal and neonatal outcomes across different platelet count strata in pregnant women with severe thrombocytopenia. Methods: We conducted a retrospective analysis of 175 cases over an 8-year period. Etiology, maternal characteristics, and maternal-neonatal outcomes were compared across 3 platelet count strata: ≤10, >10 to ≤20 × 10 Results: Primary immune thrombocytopenia was the predominant etiology (62.3%, 109/175). The incidence of postpartum hemorrhage was highest in the platelet count ≤ 10 × 10 Conclusion: Primary immune thrombocytopenia is the leading cause of severe thrombocytopenia during pregnancy. A lower platelet count, particularly ≤10 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.